The IFN-γ–Dependent Suppressor of Cytokine Signaling 1 Promoter Activity Is Positively Regulated by IFN Regulatory Factor-1 and Sp1 but Repressed by Growth Factor Independence-1b and Krüppel-Like Factor-4, and It Is Dysregulated in Psoriatic Keratinocytes
暂无分享,去创建一个
[1] D. Threadgill,et al. EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. , 2010, The Journal of investigative dermatology.
[2] C. Koelsche,et al. Structural and functional analysis of a nuclear localization signal in SOCS1. , 2009, Molecular immunology.
[3] J. Bertoglio,et al. Sp2 regulates interferon-gamma-mediated socs1 gene expression. , 2009, Molecular immunology.
[4] Wei Zhang,et al. Krüppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines , 2009, Biological chemistry.
[5] K. Heeg,et al. Identification of a nuclear localization signal in suppressor of cytokine signaling 1 , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] C. Albanesi,et al. Suppressor of cytokine signaling 1 inhibits IFN‐γ inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Hiu Kiu,et al. SOCS regulation of the JAK/STAT signalling pathway. , 2008, Seminars in cell & developmental biology.
[8] R. Rottapel,et al. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins , 2008, Immunological reviews.
[9] Z. Madar. Faculty Opinions recommendation of SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta. , 2008 .
[10] C. Albanesi,et al. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. , 2007, Clinics in dermatology.
[11] E. Tschachler. Psoriasis: the epidermal component. , 2007, Clinics in dermatology.
[12] Khusru Asadullah,et al. Immunopathogenesis of psoriasis , 2007, Experimental dermatology.
[13] L. Flowers,et al. Both the Suppressor of Cytokine Signaling 1 (SOCS-1) Kinase Inhibitory Region and SOCS-1 Mimetic Bind to JAK2 Autophosphorylation Site: Implications for the Development of a SOCS-1 Antagonist1 , 2007, The Journal of Immunology.
[14] Amy Li,et al. Establishment of 3D organotypic cultures using human neonatal epidermal cells , 2007, Nature Protocols.
[15] Alison M. Urvalek,et al. Sumoylation Delimits KLF8 Transcriptional Activity Associated with the Cell Cycle Regulation* , 2006, Journal of Biological Chemistry.
[16] P. Moore,et al. Analysis of IFN-κ Expression in Pathologic Skin Conditions: Downregulation in Psoriasis and Atopic Dermatitis , 2006 .
[17] B. Rovin,et al. Activation of the Nrf2/antioxidant response pathway increases IL‐8 expression , 2005, European journal of immunology.
[18] R. Bernards,et al. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.
[19] L. Flowers,et al. Treatment of Mice with the Suppressor of Cytokine Signaling-1 Mimetic Peptide, Tyrosine Kinase Inhibitor Peptide, Prevents Development of the Acute Form of Experimental Allergic Encephalomyelitis and Induces Stable Remission in the Chronic Relapsing/Remitting Form1 , 2005, The Journal of Immunology.
[20] C. Albanesi,et al. Keratinocytes in inflammatory skin diseases. , 2005, Current drug targets. Inflammation and allergy.
[21] L. Platanias. Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.
[22] P. Gain,et al. Cell and tissue specific expression of human Krüppel-like transcription factors in human ocular surface. , 2004, Molecular vision.
[23] J. Segre,et al. Transcriptional control of epidermal specification and differentiation. , 2004, Current opinion in genetics & development.
[24] J. Bertoglio,et al. STAT6 and Ets-1 Form a Stable Complex That Modulates Socs-1 Expression by Interleukin-4 in Keratinocytes* , 2004, Journal of Biological Chemistry.
[25] A. Bowcock,et al. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.
[26] Xiaojing Ma,et al. Differential Regulation of Interleukin (IL)-12 p35 and p40 Gene Expression and Interferon (IFN)-γ–primed IL-12 Production by IFN Regulatory Factor 1 , 2003, The Journal of experimental medicine.
[27] G. Stein,et al. The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 Promoter* , 2003, Journal of Biological Chemistry.
[28] J. Segre,et al. Ectopic expression of Kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier , 2003, Development.
[29] R. Rottapel,et al. Regulation of cytokine receptor signaling by SOCS1 , 2003, Immunological reviews.
[30] A. Yoshimura,et al. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes. , 2003, The Journal of investigative dermatology.
[31] R. Urrutia,et al. Sp1- and Krüppel-like transcription factors , 2003, Genome Biology.
[32] Chi-Chuan Tseng,et al. Gut-enriched Krüppel-like Factor Represses Ornithine Decarboxylase Gene Expression and Functions as Checkpoint Regulator in Colonic Cancer Cells* , 2002, The Journal of Biological Chemistry.
[33] Giampiero Girolomoni,et al. Impaired IFN-γ-Dependent Inflammatory Responses in Human Keratinocytes Overexpressing the Suppressor of Cytokine Signaling 11 , 2002, The Journal of Immunology.
[34] D. Choubey,et al. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes , 2002, Oncogene.
[35] A. Jegalian,et al. Regulation of Socs Gene Expression by the Proto-oncoprotein GFI-1B , 2002, The Journal of Biological Chemistry.
[36] C. Albanesi,et al. A cytokine‐to‐chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases , 2001, Journal of leukocyte biology.
[37] A. Giannetti,et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. , 2001, The Journal of allergy and clinical immunology.
[38] M. Goebeler,et al. Chemokines in cutaneous wound healing , 2001, Journal of leukocyte biology.
[39] B. Nickoloff,et al. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. , 2000, The journal of investigative dermatology. Symposium proceedings.
[40] C. Albanesi,et al. IL-4 Enhances Keratinocyte Expression of CXCR3 Agonistic Chemokines1 , 2000, The Journal of Immunology.
[41] D. Metcalf,et al. The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Fujimoto,et al. IFN Regulatory Factor-1-Mediated Transcriptional Activation of Mouse STAT-Induced STAT Inhibitor-1 Gene Promoter by IFN-γ1 , 2000, The Journal of Immunology.
[43] S. Nagata,et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Albanesi,et al. IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α , 1999, The Journal of Immunology.
[45] Dwight C. Look,et al. Stat1 Depends on Transcriptional Synergy with Sp1 (*) , 1995, The Journal of Biological Chemistry.
[46] T. Hirano,et al. Triggering of the Human Interleukin-6 Gene by Interferon-γ and Tumor Necrosis Factor-α in Monocytic Cells Involves Cooperation between Interferon Regulatory Factor-1, NFκB, and Sp1 Transcription Factors (*) , 1995, The Journal of Biological Chemistry.
[47] A. Deisseroth,et al. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter , 1993, Molecular and cellular biology.
[48] I. Campbell,et al. Keratinocyte expression of intercellular adhesion molecule 1 (ICAM‐1) correlated with infiltration of lymphocyte function associated antigen 1 (LFA‐1) positive cells in evolving allergic contact dermatitis reactions , 1991, Histopathology.
[49] D. Macdonald,et al. Alterations induced in normal human skin by in vivo interferon‐gamma , 1990, The British journal of dermatology.
[50] S. Boyce,et al. Study of HLA-DR synthesis in cultured human keratinocytes. , 1986, The Journal of investigative dermatology.
[51] Merlin Crossley,et al. Krüppel-like transcription factors: a functional family. , 2008, The international journal of biochemistry & cell biology.
[52] W. Heath,et al. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. , 2006, Tissue antigens.
[53] P. Moore,et al. Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[54] A. Frischauf,et al. IL-4 and IL-13 Induce SOCS-1 Gene Expression in A549 Cells by Three Functional STAT6-Binding Motifs Located Upstream of the Transcription Initiation Site , 2003 .
[55] C. Albanesi,et al. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. , 1999, Journal of immunology.
[56] T. Hirano,et al. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. , 1995, The Journal of biological chemistry.